Back to Search
Start Over
Assessment of ex-vivo efficacy of immunotherapeutic agents in intermediate-risk and high-risk non-muscle invasive bladder cancer
- Publication Year :
- 2021
-
Abstract
- Assessment of ex-vivoefficacy of immunotherapeutic agents in intermediate-risk and high-risknon-muscle invasive bladder cancer
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......2605..03ee14ae55a4a06a3dd8dce590923706